nephrogenbiotech.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Nephrogen
Description We’re building curative gene therapies for life threatening kidney Nephrogen is a therapeutics company developing transformative medicines for kidney disease. Our initial focus is on gene therapy for autosomal dominant polycystic kidney disease
Keywords N/A
Server Information
WebSite nephrogenbiotech faviconnephrogenbiotech.com
Host IP 99.83.190.102
Location United States
Related Websites
Site Rank
More to Explore
nephrogenbiotech.com Valuation
US$578,695
Last updated: 2023-05-16 12:56:00

nephrogenbiotech.com has Semrush global rank of 18,289,955. nephrogenbiotech.com has an estimated worth of US$ 578,695, based on its estimated Ads revenue. nephrogenbiotech.com receives approximately 66,773 unique visitors each day. Its web server is located in United States, with IP address 99.83.190.102. According to SiteAdvisor, nephrogenbiotech.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$578,695
Daily Ads Revenue US$535
Monthly Ads Revenue US$16,026
Yearly Ads Revenue US$192,305
Daily Unique Visitors 4,452
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
nephrogenbiotech.com. A 3599 IP: 99.83.190.102
nephrogenbiotech.com. A 3599 IP: 75.2.70.75
nephrogenbiotech.com. NS 3600 NS Record: ns41.domaincontrol.com.
nephrogenbiotech.com. NS 3600 NS Record: ns42.domaincontrol.com.
nephrogenbiotech.com. MX 3600 MX Record: 0 nephrogenbiotech-com.mail.protection.outlook.com.
nephrogenbiotech.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-16 12:56:00
ABOUT Technology Team News Contact We’re building curative gene therapies for life threatening kidney diseases. Launch your product — and savor the momentum. Get the App research and advisors from OUR MISSION Nephrogen is a seed-stage biotech company developing curative gene therapies for kidney diseases . Our initial indication is autosomal dominant polycystic kidney disease (ADPKD), which affects 600,000 Americans and has no cure or effective treatment. Tolvaptan (JYNARQUE®) is the only FDA approved drug for ADPKD, costs $13K for a 28-day supply, and must be taken twice daily for decades for maximum benefit. Our solution aims to halt ADPKD from the onset and provide an outright cure for the disease. We’re boldly committed to reimagining therapeutics for life threatening kidney disease. Our broad patent portfolio will allow us to rapidly translate our technologies into foundational partnerships and transformative treatments. Our technology Curative gene therapies for kidney diseases.
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: openresty
Date: Wed, 26 Jan 2022 12:28:13 GMT
Content-Type: text/html
Content-Length: 166
Connection: keep-alive
Location: https://nephrogenbiotech.com/

HTTP/2 301 
server: openresty
date: Wed, 26 Jan 2022 12:28:14 GMT
content-type: text/html
content-length: 166
location: https://www.nephrogenbiotech.com/

HTTP/2 200 
server: openresty
date: Wed, 26 Jan 2022 12:28:14 GMT
content-type: text/html
content-length: 28121
x-lambda-id: 28b0a7ad-9d67-42c3-82b0-12e3394e15ab
via: 1.1 varnish, 1.1 varnish
accept-ranges: bytes
age: 17708
x-served-by: cache-iad-kiad7000103-IAD, cache-dub4351-DUB
x-cache: HIT, HIT
x-cache-hits: 1, 1
x-timer: S1643200095.633218,VS0,VE3
vary: Accept-Encoding
x-cluster-name: eu-west-1-prod-eks-15
nephrogenbiotech.com Whois Information
Domain Name: NEPHROGENBIOTECH.COM
Registry Domain ID: 1979172657_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-09-23T16:32:50Z
Creation Date: 2015-11-13T05:30:59Z
Registry Expiry Date: 2022-11-13T05:30:59Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS41.DOMAINCONTROL.COM
Name Server: NS42.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-01-26T07:56:21Z <<<